Patients with p16-positive oropharyyngeal HNSCC exhibited a superior overall survival compared to those with p16-negative HNSCC; making p16 IHC a convenient surrogate marker for HPV detection in HNSCC. Here, CDKN2A is linked to head and neck squamous cell carcinoma.